Inhibition of interleukin-1 and tumor necrosis factor-α synthesis following treatment of macrophages with the kappa opioid agonist U50,488H

Journal of Pharmacology and Experimental Therapeutics

Volumn 273, Issue 3, 1995, Pages 1491-1496

  Belkowski, S M ^a   Alicea, C ^a   Eisenstein, T K ^a   Adler, M W ^a   Rogers, T J ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 6; KAPPA OPIATE RECEPTOR; LIPOPOLYSACCHARIDE; MESSENGER RNA; NALOXONE; NORBINALTORPHIMINE; OPIATE AGONIST; TUMOR NECROSIS FACTOR ALPHA;

ACCESSORY CELL; ANIMAL CELL; ARTICLE; BIOASSAY; CELL CULTURE; CONTROLLED STUDY; IMMUNE RESPONSE; MACROPHAGE; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANALGESICS; ANIMAL; BLOTTING, NORTHERN; CELL LINE; INTERLEUKIN-1; INTERLEUKIN-6; MACROPHAGES; MICE; NALOXONE; PYRROLIDINES; RECEPTORS, OPIOID, KAPPA; RNA, MESSENGER; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR NECROSIS FACTOR;

EID: 0029053172     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)